Estrella Immunopharma stockholders ratify auditor at 2025/2026 annual meeting

Estrella Immunopharma, Inc.

Ratified Macias Gini & O'Connell LLP as independent auditor for fiscal year ending Dec 31, 2026.
Votes: 30,351,203 for, 400 against, 5 abstain; no broker non-votes.
Annual meeting held June 29, 2026; quorum of ~70.5% of outstanding shares.

item 5.07

Estrella Immunopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-073847

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.